Nivolumab Plus Ipilimumab Versus EXTREME Regimen as First-Line Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: The Final Results of CheckMate 651
纳武利尤单抗联合伊匹木单抗对比 EXTREME 方案作为复发/转移性头颈部鳞状细胞癌一线治疗:CheckMate 651 研究的最终结果
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.22.00332
Haddad, Robert I; Harrington, Kevin; Tahara, Makoto; Ferris, Robert L; Gillison, Maura; Fayette, Jerome; Daste, Amaury; Koralewski, Piotr; Zurawski, Bogdan; Taberna, Miren; Saba, Nabil F; Mak, Milena; Kawecki, Andrzej; Girotto, Gustavo; Alvarez Avitia, Miguel Angel; Even, Caroline; Toledo, Joaquin Gabriel Reinoso; Guminski, Alexander; Müller-Richter, Urs; Kiyota, Naomi; Roberts, Mustimbo; Khan, Tariq Aziz; Miller-Moslin, Karen; Wei, Li; Argiris, Athanassios